In industries such as pharmaceuticals, fine chemicals, and nutraceuticals, precision in dry processing and bulk solids handling is critical. Consistency, safety, and product quality depend on advanced blending technology that can keep up with evolving production demands. Companies are increasingly investing in automated and reliable systems to ensure efficient workflows, safeguard materials, and maintain the highest levels of compliance.
Dry blending is a vital step in the production of pharmaceutical drugs. These substances are usually powders but may also be in the form of granules. The active pharmaceutical ingredient or API is blended with a non-active ingredient known as an excipient to produce tablets. The excipients can serve different purposes; for example, they can serve as carriers for the active ingredient.
The dry processing and bulk solids handling industry is being pushed by immense and formidable social and economic forces, primarily a global pandemic, that may have forever changed how we interact and work.
The pandemic has revealed the critical need for the dry processing and bulk solids handling sector to implement more advanced manufacturing technologies.
The pandemic has revealed the critical need for the dry processing and bulk solids handling sector to implement more advanced manufacturing technologies.




